Mind Medicine Mindmed Inc (MNMD) Stock Price, Quote & News

Company Profile

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is head...

Industry: Biotechnology

Sector: Healthcare

Phone: 212 220 6633

Website: www.mindmed.co

Address:

One World Trade Center, Suite 8500, New York, United States

a_rational_investor Jul. 31 at 1:24 AM

$MNMD let’s go!

0 · Reply

MichaelNaussCMT Jul. 31 at 12:56 AM

$MNMD the buyouts are starting. $50

1 · Reply

twiggs462 Jul. 31 at 12:18 AM

$MNMD AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal https://www.bloomberg.com/news/articles/2025-07-30/abbvie-is-said-in-talks-to-acquire-gilgamesh-in-1-billion-deal?srnd=prognosis&embedded-checkout=true&leadSource=reddit_wall “MindMed, Cybin and Gilgamesh are leading efforts in a fast-moving field aimed at large, underserved populations, with consensus projecting about $4.5 billion in sales for the segment by 2032,” he said in a note in April.

0 · Reply

Bulltrader988 Jul. 30 at 6:50 PM

$MNMD tomorrow after market 👃👀

0 · Reply

twiggs462 Jul. 30 at 2:44 PM

$ATAI $MNMD $CMPS - NEW 10 Episode Podcast coming... BBC UK - The Trip - Starts next week. https://www.bbc.co.uk/programmes/m001dwr7/episodes/guide

1 · Reply

DCRMIA Jul. 30 at 1:32 PM

$MNMD

0 · Reply

Bulltrader988 Jul. 29 at 8:10 PM

$MNMD thursday after market 👃👀

0 · Reply

twiggs462 Jul. 29 at 7:29 PM

$ATAI $MNMD $CMPS Psychedelic Science 2025: Lessons From MDMA Trials Could Strengthen Future Psychedelic Approvals - https://www.pharmacytimes.com/view/psychedelic-science-2025-lessons-from-mdma-trials-could-strengthen-future-psychedelic-approvals

0 · Reply

twiggs462 Jul. 29 at 7:21 PM

$ATAI $MNMD $ATAI Psychedelic Therapy Crashed and Burned. MAHA Might Bring It Back - https://www.wired.com/story/psychedelic-therapy-mdma-maha/

0 · Reply

twiggs462 Jul. 29 at 7:10 PM

$ATAI $MNMD $CMPS - There are only so many CNPV Vouchers that the FDA will hand out. If one of these companies recevies one the stock price will react like a buyout or FDA approval because it will show conviction from the FDA side. That alone is worth approval or credibility for a buyout candidate. All you need is one and the entire sector will go wild. But there could be that one gemstone you are holding that will surprise you. We just simply don't know, but if it does happen. Wow... Watch out.

2 · Reply

MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025

Jul 14, 2025, 4:01 PM EDT - 16 days ago

MindMed Announces New Employee Inducement Grants

May 28, 2025, 7:00 AM EDT - 2 months ago

MindMed to Participate in June Investor Conferences

May 27, 2025, 7:00 AM EDT - 2 months ago

MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer

May 13, 2025, 7:00 AM EDT - 2 months ago

MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference

May 8, 2025, 9:55 AM EDT - 2 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q1 2025 Earnings Call Transcript

May 8, 2025, 7:00 AM EDT - 2 months ago

MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates

Apr 24, 2025, 7:00 AM EDT - 3 months ago

MindMed to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 15, 2025, 7:00 AM EDT - 3 months ago

MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)

Mar 17, 2025, 7:00 AM EDT - 4 months ago

MindMed Appoints Matt Wiley as Chief Commercial Officer

Mar 6, 2025, 12:10 PM EST - 5 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 7:00 AM EST - 5 months ago

MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates

Mar 4, 2025, 7:00 AM EST - 5 months ago

MindMed to Present at Leerink's Global Healthcare Conference 2025

Feb 20, 2025, 7:00 AM EST - 5 months ago

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Feb 4, 2025, 7:00 AM EST - 6 months ago

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 30, 2025, 7:00 AM EST - 6 months ago

MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder

Dec 19, 2024, 7:00 AM EST - 7 months ago

MindMed to Be Added to the Nasdaq Biotechnology Index

Dec 16, 2024, 7:00 AM EST - 8 months ago

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)

Dec 11, 2024, 7:00 AM EST - 8 months ago

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress

Dec 5, 2024, 7:00 AM EST - 8 months ago

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)

Dec 3, 2024, 7:00 AM EST - 8 months ago

MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy

Nov 18, 2024, 7:00 AM EST - 9 months ago

MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer

Nov 13, 2024, 7:00 AM EST - 9 months ago

MindMed to Participate in Upcoming Investor Conferences

Nov 10, 2024, 9:55 AM EST - 9 months ago

Mind Medicine: No News = Good News

Nov 7, 2024, 8:06 PM EST - 9 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:01 PM EST - 9 months ago

MindMed Reports Third Quarter 2024 Financial Results and Business Updates

Nov 4, 2024, 4:04 PM EST - 9 months ago

Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate

Oct 24, 2024, 7:00 AM EDT - 9 months ago

MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update

Sep 4, 2024, 7:00 AM EDT - 11 months ago

MindMed to Participate in September Investor Conferences

Aug 15, 2024, 12:30 PM EDT - 1 year ago

Psychedelic Stocks: Focus On Their Cash

CMPS

Aug 13, 2024, 11:21 AM EDT - 1 year ago

Mind Medicine (MindMed) Inc. (MNMD) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 7:44 AM EDT - 1 year ago

MindMed readying Phase III trials for LSD therapy to treat anxiety

Aug 13, 2024, 7:01 AM EDT - 1 year ago

Pacific Defense Announces US Army CMFF Program Team

MRNS

Aug 13, 2024, 7:00 AM EDT - 1 year ago

MindMed Reports Second Quarter 2024 Financial Results and Business Updates

Aug 12, 2024, 12:47 PM EDT - 1 year ago

FDA Rejection of MDMA Therapy Isn't End of Psychedelic-Drug Candidates

Aug 12, 2024, 12:12 PM EDT - 1 year ago

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

ATAI CMPS CYBN

Aug 9, 2024, 8:44 AM EDT - 1 year ago

Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering

Aug 9, 2024, 6:00 AM EDT - 1 year ago

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Aug 7, 2024, 2:29 PM EDT - 1 year ago

MindMed And Other Psychedelic Stocks Brace For FDA's Decision On MDMA Therapy

Aug 6, 2024, 4:01 PM EDT - 1 year ago

MindMed to Present at Canaccord Genuity's 44th Annual Growth Conference

Aug 6, 2024, 7:00 AM EDT - 1 year ago

MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update

Jul 29, 2024, 7:00 AM EDT - 1 year ago

MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer

Jul 17, 2024, 7:00 AM EDT - 1 year ago

MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)

Jun 28, 2024, 7:00 AM EDT - 1 year ago

MindMed to be Included in Russell 2000® and Russell 3000® Indexes

Jun 21, 2024, 7:00 AM EDT - 1 year ago

MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Jun 20, 2024, 7:00 AM EDT - 1 year ago

MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)

Jun 5, 2024, 11:46 AM EDT - 1 year ago

MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors

May 28, 2024, 7:00 AM EDT - 1 year ago

MindMed to Participate in June Conferences

May 23, 2024, 12:15 PM EDT - 1 year ago

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

CMPS

May 9, 2024, 4:01 PM EDT - 1 year ago

MindMed to Participate at May Investor Conferences

a_rational_investor Jul. 31 at 1:24 AM

$MNMD let’s go!

0 · Reply

MichaelNaussCMT Jul. 31 at 12:56 AM

$MNMD the buyouts are starting. $50

1 · Reply

twiggs462 Jul. 31 at 12:18 AM

0 · Reply

Bulltrader988 Jul. 30 at 6:50 PM

$MNMD tomorrow after market 👃👀

0 · Reply

twiggs462 Jul. 30 at 2:44 PM

$ATAI $MNMD $CMPS - NEW 10 Episode Podcast coming... BBC UK - The Trip - Starts next week. https://www.bbc.co.uk/programmes/m001dwr7/episodes/guide

1 · Reply

DCRMIA Jul. 30 at 1:32 PM

$MNMD

0 · Reply

Bulltrader988 Jul. 29 at 8:10 PM

$MNMD thursday after market 👃👀

0 · Reply

twiggs462 Jul. 29 at 7:29 PM

0 · Reply

twiggs462 Jul. 29 at 7:21 PM

$ATAI $MNMD $ATAI Psychedelic Therapy Crashed and Burned. MAHA Might Bring It Back - https://www.wired.com/story/psychedelic-therapy-mdma-maha/

0 · Reply

twiggs462 Jul. 29 at 7:10 PM

2 · Reply

DriuxP Jul. 29 at 7:04 PM

$ATAI very happy with Atai's performance today. Looking really healthy. Obv a broad down day, but a healthy day for the sector as well. Trying to suppress these butterflies. I try not to get excited about the day to day, or week to week movement. After all, I'm planning on holding indefinitely. We're buying Amazon in '97 here, folks. A lot of the detractors here would have looked to Barnes and Noble to explain why Amazon wasn't worth investing in. How much can you really make selling books on this "internet"? They'll say, "how much can a fungus that grows on poop or other hippie drugs change the world??" Well, I say, buckle the F up and keep your eyes open. $PSIL $CMPS $MNMD

2 · Reply

twiggs462 Jul. 29 at 4:12 PM

$MNMD $ATAI $CMPS - Compass and ATAI latest news + are Psychedelics BACK in 2025?! https://www.youtube.com/watch?v=6OiDBf26nF0

0 · Reply

twiggs462 Jul. 29 at 4:11 PM

$MNMD $ATAI $CMPS - Could psychedelic medicine solve the mental health crisis? https://www.emjreviews.com/en-us/amj/emj-gold/news/could-psychedelic-medicine-solve-the-mental-health-crisis/

2 · Reply

McGuireTO Jul. 29 at 12:17 AM

$MNMD very healthy sideways consolidation after a 54% surge over the last 4 weeks. 4hr downtrend is our guide and lower lows aren't seeing much followthrough, giving clues there may be a daily bullflag pattern shaping up. EARNINGS THIS WEEK! Support: 9.53, 9.37 Resistance: 9.79, 9.82, 10.09 I post regular analysis of the psychedelics sector, please like and follow to make sure you don't miss my next update! https://www.tradingview.com/chart/MNMD/yYBZS9ce-MNMD-healthy-sideways-consolidation/

0 · Reply

Bulltrader988 Jul. 28 at 6:12 PM

$MNMD Thursday 👃👀

0 · Reply

DCRMIA Jul. 28 at 4:26 PM

$MNMD

0 · Reply

a_rational_investor Jul. 28 at 3:29 PM

$MNMD why is the sentiment so low

1 · Reply

a_rational_investor Jul. 28 at 3:28 PM

$MNMD it’s weird buying in the 9’s after hammering the 6’s